Open Interest and Volume Dynamics
On 22 May 2026, Glenmark's open interest (OI) in derivatives climbed from 40,902 contracts to 47,055, an increase of 6,153 contracts or 15.04%. This rise in OI was accompanied by a futures volume of 41,678 contracts, indicating robust trading activity. The combined futures and options value stood at approximately ₹13,179.63 crores, with futures alone accounting for ₹1,295.41 crores. The underlying stock price closed at ₹2,281, having touched an intraday low of ₹2,272.3, down 5.04% on the day.
The weighted average price for the day skewed towards the lower end of the intraday range, suggesting that a majority of trades occurred closer to the day's low. This price action, combined with rising OI, points to increased participation at lower price levels, possibly reflecting fresh short positions or protective hedging by longs.
Price Performance and Moving Averages
Despite the surge in derivatives activity, Glenmark underperformed its Pharmaceuticals & Biotechnology sector by 4.4% and the Sensex by 6.17% on the day. The stock’s 1-day return was -5.61%, compared to the sector’s -0.71% and Sensex’s positive 0.56%. Notably, the stock traded above its 50-day, 100-day, and 200-day moving averages but below its 5-day and 20-day averages, indicating short-term weakness within a longer-term uptrend.
Investor participation also showed signs of waning, with delivery volumes on 21 May falling by 54.67% against the 5-day average delivery volume, registering at 1.57 lakh shares. This decline in delivery volume suggests reduced conviction among long-term holders amid the recent price weakness.
Market Positioning and Directional Bets
The sharp increase in open interest alongside a price decline often signals that new short positions are being established, or existing shorts are being added to, as traders anticipate further downside. Alternatively, it could reflect longs hedging their positions through options and futures, especially given the substantial options value exceeding ₹24,053 crores, which dwarfs futures value and indicates active options market participation.
Given Glenmark’s mid-cap status with a market capitalisation of ₹67,402 crores and a recent upgrade in its Mojo Grade from Buy to Strong Buy on 19 May 2026, the derivatives activity may also represent strategic positioning ahead of anticipated fundamental developments. The Mojo Score of 81.0 supports a positive medium-term outlook, suggesting that some market participants may be positioning for a rebound despite short-term weakness.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Liquidity and Trading Considerations
Liquidity remains adequate for sizeable trades, with the stock’s traded value representing approximately 2% of its 5-day average traded value, allowing for trade sizes up to ₹2.85 crores without significant market impact. This liquidity supports active participation from institutional and retail traders alike in both the cash and derivatives segments.
However, the falling delivery volumes and the stock’s underperformance relative to its sector and benchmark indices suggest caution. The divergence between short-term moving averages and longer-term averages highlights a potential consolidation or correction phase within an overall bullish medium-term trend.
Implications for Investors and Traders
For investors, the recent upgrade to a Strong Buy rating by MarketsMOJO, supported by a high Mojo Score, underscores confidence in Glenmark’s fundamentals and growth prospects. Yet, the current derivatives market activity and price weakness imply that traders are hedging or speculating on near-term volatility.
Traders should closely monitor open interest trends alongside price action to gauge whether the recent OI surge translates into sustained directional moves. A continued rise in OI with stabilising or rising prices would confirm fresh long accumulation, while rising OI amid falling prices would reinforce bearish sentiment.
Options market participants, given the substantial options value, may be employing complex strategies such as protective puts or spread trades to manage risk or capitalise on expected volatility.
Curious about Glenmark Pharmaceuticals Ltd. from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Conclusion
The pronounced increase in open interest for Glenmark Pharmaceuticals Ltd. on 22 May 2026, amid a notable price decline and mixed volume signals, reflects a complex interplay of market forces. While the stock’s medium-term outlook remains positive as per MarketsMOJO’s Strong Buy rating and robust Mojo Score, short-term traders appear to be positioning for volatility, possibly anticipating further price adjustments or hedging existing exposures.
Investors should weigh the current derivatives market signals alongside fundamental strengths and sector trends before making allocation decisions. Monitoring subsequent open interest changes, price movements relative to key moving averages, and delivery volumes will be crucial to discerning the prevailing market sentiment and directional bias for Glenmark Pharmaceuticals.
Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →
